A widely used arthritis drug did not help inflammatory knee osteoarthritis in a recent trial

A recent randomized, placebo-controlled clinical trial found that low-dose methotrexate did not significantly improve knee pain or joint inflammation in people with inflammatory knee osteoarthritis over 52 weeks. For patients hoping a drug used for rheumatoid arthritis might also help osteoarthritis, the result is an important reality check.

The practical takeaway is not that osteoarthritis has no inflammatory component, or that anti-inflammatory treatment can never help. It is that osteoarthritis and rheumatoid arthritis are different diseases, and a medicine that works for one does not automatically work for the other.

What the new study found

The trial, published in JAMA Internal Medicine, tested low-dose methotrexate against placebo in people with inflammatory knee osteoarthritis. Because participants were randomly assigned to treatment or placebo, this study design is more reliable than anecdotes, case reports, or observational research when it comes to judging whether a drug truly helps.

Over a year of follow-up, methotrexate did not produce a statistically significant improvement in knee pain or synovitis, which is inflammation in the lining of the joint, compared with placebo in the study population.

That matters because inflammatory features in knee osteoarthritis have led some researchers to wonder whether a disease-modifying drug used in autoimmune arthritis might reduce symptoms here too. In this trial, that did not happen in a meaningful way.

Why people may have expected methotrexate to work

Methotrexate is a well-known treatment for rheumatoid arthritis, an autoimmune disease in which the immune system attacks the joints and causes ongoing inflammation. Osteoarthritis is different. It involves changes in cartilage, bone, joint tissues, and mechanics over time. In many people, especially in painful flare-ups or more active disease, inflammation can still be part of the picture. But that does not make osteoarthritis the same as rheumatoid arthritis.

That distinction is easy to miss. If both conditions can involve painful, swollen joints, it may seem logical that the same anti-inflammatory drug would help both. This study suggests it is not that simple.

What this study does not mean

One negative trial should not be stretched beyond what it actually showed.

First, the study focused on a specific group: people with inflammatory knee osteoarthritis. Osteoarthritis is not one single uniform condition. Different joints, symptom patterns, imaging findings, and inflammatory features may matter. So this trial does not prove methotrexate would never help any person with any form of osteoarthritis.

Second, it also does not prove that every anti-inflammatory approach fails in osteoarthritis. It tells us that in this randomized, placebo-controlled trial, low-dose methotrexate did not significantly improve the main outcomes researchers were tracking.

Still, for everyday care, the result is useful. It argues against assuming that a rheumatoid arthritis drug will help knee osteoarthritis simply because the knee looks inflamed.

What treatments still have the best evidence for knee osteoarthritis

For most people with knee osteoarthritis, the strongest evidence still supports a mix of movement-based care, self-management, and symptom relief tailored to the person.

Guideline summaries from the American Family Physician and the Arthritis Foundation continue to emphasize several core options.

Exercise and physical activity

Exercise remains one of the most consistently recommended treatments for knee osteoarthritis. That can include walking, strengthening exercises, physical therapy, tai chi, water exercise, or other low-impact activity. MedlinePlus notes that staying active can help reduce pain and stiffness and improve function.

The key is choosing activity that feels sustainable and safe. People often worry that movement will worsen joint damage, but appropriate activity is usually part of treatment, not something to avoid entirely.

Weight loss, if relevant

For people who carry excess weight, even modest weight loss can reduce stress on the knees and improve symptoms. This is not about blame. It is about lowering the mechanical load on a painful joint and, in some cases, reducing inflammatory signals linked with body fat.

Self-management support

Structured self-management programs can help people learn pacing strategies, activity planning, pain coping skills, and ways to stay active during flare-ups. These steps may sound simple, but they can make day-to-day symptoms easier to manage.

Topical or oral NSAIDs

Nonsteroidal anti-inflammatory drugs, or NSAIDs, are commonly used for symptom relief. Topical NSAIDs may be a good option for some people because they act locally and may pose fewer whole-body side effects than pills. Oral NSAIDs can help too, but they are not right for everyone.

People with kidney disease, stomach ulcers, bleeding risk, uncontrolled high blood pressure, or certain heart conditions should talk with a clinician before using them regularly. The safest choice depends on the person.

Injections in selected cases

Some injections may offer limited symptom relief for selected patients, but they are not a cure and do not work equally well for everyone. Whether an injection makes sense depends on the cause of pain, prior treatment response, other health conditions, and the clinician’s judgment.

For readers, the bigger point is that injections are usually one part of symptom management, not a substitute for the basics like activity, strengthening, and weight management when appropriate.

When to talk with a clinician

If knee pain is persistent, worsening, affecting sleep, limiting walking, or causing swelling, locking, or giving way, it is worth getting evaluated. Not all joint pain is osteoarthritis. A clinician may need to rule out other causes, including gout, an injury, infection, inflammatory arthritis, or referred pain from somewhere else.

People should also seek care sooner if a joint becomes suddenly very swollen, red, hot, or hard to move, or if fever is involved.

What this means for readers

This trial does not erase the fact that osteoarthritis can involve inflammation. It does show that low-dose methotrexate, a drug widely used for rheumatoid arthritis, did not significantly improve pain or synovitis in this specific group with inflammatory knee osteoarthritis over 52 weeks.

For most people living with knee OA, the best-supported next step is still to discuss proven options: regular physical activity, strengthening or physical therapy, weight loss if relevant, self-management strategies, and carefully chosen symptom-relief treatments such as topical or oral NSAIDs or selected injections when appropriate.

In short, a treatment that helps one kind of arthritis may not help another. That is disappointing, but it is also useful information that can steer patients toward care with better evidence behind it.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.